|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
|2.||Atopic Dermatitis (Atopic Eczema)
|1.||Hashimoto, Takashi: 34 articles (11/2015 - 01/2005)|
|2.||Hashimoto, T: 20 articles (12/2014 - 05/2000)|
|3.||Ishii, Norito: 19 articles (11/2015 - 07/2008)|
|4.||Zillikens, Detlef: 19 articles (05/2015 - 03/2002)|
|5.||Zillikens, D: 15 articles (01/2011 - 02/2000)|
|6.||Feldman, Steven R: 14 articles (06/2014 - 01/2003)|
|7.||Ruzicka, Thomas: 14 articles (05/2012 - 07/2003)|
|8.||Koga, Hiroshi: 13 articles (10/2015 - 07/2011)|
|9.||Werfel, Thomas: 12 articles (01/2015 - 06/2005)|
|10.||Luger, T A: 12 articles (07/2009 - 01/2000)|
|1.||Cyclosporine (Ciclosporin)FDA LinkGeneric
12/01/2010 - "Cyclosporine is highly effective in the treatment of a multitude of dermatoses. "
01/01/2007 - "We present the third documented case of this uncommon dermatosis, which was treated successfully with orally administered cyclosporine. "
09/01/1998 - "Effective treatment of persistent papular acantholytic dermatosis with cyclosporine."
04/01/1996 - "A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses."
07/01/1992 - "Cyclosporin is effective in the treatment of many dermatoses, and although the immunosuppressive effects of cyclosporin are mainly attributed to inhibition of T-lymphocyte proliferation, it has also been shown to affect the functions of both neutrophils and monocytes. "
08/01/2013 - "Overall, ALA/PDT and MAL/PDT are effective for a variety of skin diseases and conditions. "
07/01/2002 - "PDT may also be effective in various inflammatory and infectious dermatoses. "
06/01/2006 - "Optimum parameters for PDT need to be established and comparison randomised studies are required to clarify whether PDT for benign dermatoses is significantly superior to existing therapeutic modalities. "
02/01/2002 - "The relevant literature will be discussed and the potential for topical PDT in the treatment of several skin diseases is highlighted, although more detailed studies are required to clarify the role of PDT beyond the treatment of NMSC."
01/01/2002 - "However, controlled clinical trials are still needed to demonstrate more fully the effectiveness of PDT for inflammatory skin diseases."
|3.||Tacrolimus (Prograf)FDA LinkGeneric
03/01/2010 - "Topical tacrolimus has shown remarkable clinical efficacy in treating many dermatoses. "
02/01/2011 - "Tacrolimus, though beneficial in other dermatoses, could not be considered effective in the treatment of AA."
06/01/1998 - "Recently, it has been shown that the immunosuppressive macrolide lactone, FK506, exerts good therapeutic efficacy in inflammatory skin diseases. "
05/17/1996 - "This widespread skin disease can be effectively treated with the microbial substance FK506, which acts by modulating gene expression. "
09/01/2003 - "Clinical trials have demonstrated the efficacy of FK-506 (an immunosuppressive macrolide) ointment for AD, and many case reports have been published regarding its positive effects for other inflammatory skin diseases. "
07/01/1988 - "Retinoids are potent therapuetic agents that have been found to be effective in a variety of skin diseases. "
07/01/1992 - "Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases."
01/01/1991 - "Systemic retinoids are effective in a variety of inflammatory dermatoses. "
10/01/1997 - "To study the potential efficacy of retinoids on granulocytes with regard to their role in inflammatory dermatoses. "
01/01/1993 - "Systemic retinoids are used in the management of chronic cutaneous conditions and life-threatening dermatoses. "
|5.||Adrenal Cortex Hormones (Corticosteroids)IBA
01/01/2006 - "These findings provided the first pharmacological evidence of the efficacy of this novel class of topical agents in the treatment of inflammatory skin diseases, and, thus, their potential to become the first alternative to corticosteroids in more than 40 years. "
02/01/1980 - "The development of topical corticosteroids has enabled many dermatoses to be more effectively treated than previously, but there is also no doubt that misuse of these preparations can lead to troublesome local effects and potentially serious systemic problems. "
01/01/2005 - "Topical corticosteroids are the mainstay of treatment in inflammatory skin diseases. "
03/01/2002 - "Topical corticosteroids are useful for the treatment of pediatric dermatoses. "
01/01/2007 - "The dermatosis responded well to corticosteroids. "
|6.||Immunoglobulin A (IgA)IBA
10/01/2015 - "Linear immunoglobulin A bullous dermatosis is a rare entity with frequent spontaneous resolution. "
12/01/2009 - "Remission of sublamina densa-type linear IgA bullous dermatosis after Helicobacter pylori eradication."
10/01/2015 - "A biopsy was performed, which was consistent with linear immunoglobulin A bullous dermatosis and later confirmed by direct immunofluorescence studies. "
04/01/2014 - "Linear IgA bullous dermatosis (LABD) is a rare autoimmune bullous disease, which is defined by the histopathological finding of subepidermal vesicles with neutrophilic infiltration and linear IgA deposits in the basement membrane zone, revealed by immunofluorescence study. "
07/01/1999 - "Linear IgA bullous dermatosis of childhood: a long-term study."
|7.||pimecrolimus (Elidel)FDA Link
10/01/2002 - "The latter also indicates that pimecrolimus should be equally effective in other inflammatory skin diseases."
12/01/2004 - "In conclusion, the results of preclinical studies show that pimecrolimus has a selective pharmacological profile, suited for effective and safe treatment for inflammatory skin diseases."
01/01/2005 - "Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases."
01/01/2005 - "Several studies have evaluated the effectiveness of pimecrolimus as the treatment of choice for inflammatory skin diseases."
09/01/2003 - "Several studies have evaluated the effectiveness of pimecrolimus as a treatment for skin diseases. "
|8.||Anti-Bacterial Agents (Antibiotics)IBA
06/01/2009 - "In spite of existence of broad-spectrum antibiotics and antifungals for the treatment of skin diseases the efficacy of drugs aren't always successful. "
03/01/1995 - "Contrary to antibiotics, which can cause remission of dermatosis, while early relapses cannot be prevented, oral vaccine treatment leads to long-term (extending over several years) favourable effects on the course of the disease. "
01/01/1995 - "New therapeutic strategies by administering antibiotics have been found to be effective in the described Bb induced dermatoses. "
07/01/2002 - "We present a collection of clinical studies and case reports dealing with the potential benefits of systemic antibiotics in the treatment of selected dermatoses which have primarily been classified as non-infectious. "
10/01/1978 - "Our own experimental studies showed that topical antibiotics promptly reduce the density of Staphylococcus aureus in secondarily infected chronic dermatoses, associated with clinical improvement. "
|9.||Betamethasone (Celestone)FDA Link
07/01/1963 - "[TRIAL OF TREATMENT OF SEVERAL DERMATOSES WITH BETAMETHASONE]."
01/01/1987 - "[Use of external medicinal preparations containing betamethasone in the treatment of chronic dermatoses]."
06/11/1965 - "[Evaluation of a 17-valerate of betamethasone in ointment form for the topical treatment of some dermatoses]."
06/10/1965 - "[Betamethasone valerate in the treatment of some dermatoses]."
01/22/1965 - "[BETAMETHASONE IN INTRALESIONAL USE IN ALLERGIC SKIN DISEASES]."
|10.||Methoxsalen (Oxsoralen)FDA Link
04/01/2005 - "The results of the study indicate that at least 18 courses of local PUVA within 6 weeks, with a cumulative dose of 87 J/cm(2), are required to induce a significant decrease in the disease severity and an improvement in the infiltration of plaques due to 8-MOP gel at a concentration of 0.01% when treating chronic recurrent palmoplantar dermatoses."
01/01/1989 - "The administration of 8 - methoxypsoralen combined with UV-A exposure (PUVA) was found to be effective in a case of progressive pigmented purpuric dermatosis (PPPD). "
04/01/2005 - "Aims In this study, the efficacy of topical PUVA treatment with 8-methoxypsoralen (8-MOP) gel was compared with placebo plus UVA in chronic recurrent palmoplantar dermatoses. "
08/01/2015 - "8-Methoxypsoralen (8-MOP) is a well established drug in the treatment of various skin diseases. "
12/01/2012 - "The bifunctional compound furocumarin 8-methoxypsoralen (8-MOP) is widely used in the treatment of various inflammatory skin diseases. "
|1.||Phototherapy (Light Therapy)
12/01/2014 - "Phototherapy is a second-line treatment modality for the most common dermatoses that is safe and effective. "
09/01/2002 - "The use of ultraviolet B light (UVB) has been proven to be highly effective for treatment of various inflammatory skin diseases, but UVB phototherapy is limited by its carcinogenic side effects. "
12/15/2002 - "A novel improved form of UV-B phototherapy, narrowband UV-B, has been proven to be very effective in T-cell mediated dermatoses. "
12/01/2007 - "Phototherapy with narrow-band UVB (NB-UVB), with a peak exclusively at 311 nm wavelength, has been found to be more effective in treating a variety of skin diseases than conventional broad-band UVB (BB-UVB). "
04/01/2014 - "Review of an established UK home phototherapy service 1998-2011: improving access to a cost-effective treatment for chronic skin disease."
|2.||Photochemotherapy (Photodynamic Therapy)
08/01/2001 - "Photochemotherapy (PUVA) is beneficial for the treatment of various dermatoses. "
03/01/2001 - "Recently, it has been reported that bath PUVA photochemotherapy is effective for treating this dermatosis. "
12/01/2014 - "Photodynamic therapy is another non-invasive technique currently used for skin diseases. "
06/01/2013 - "European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses."
09/01/2012 - "To our knowledge, erosive pustular dermatosis of the scalp after photodynamic therapy has been seldom reported. "
09/01/2000 - "The initial interests of Dr. Leon Goldman stimulated many other individual dermatologists to further his work and develop surgical techniques using newer laser systems to provide more effective treatment for patients with a variety of skin diseases. "
09/01/2005 - "The purpose of this article is to discuss the effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses."
09/01/2005 - "Effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses."
10/01/2013 - "The efficacy of PDL laser treatment for these inflammatory skin diseases was described and evaluated. "
11/01/2010 - "Confocal laser scanning microscopy (CLSM) has been proved to be useful in the diagnosis of skin diseases; however, to date, there is no report on the differential study of the two diseases with CLSM. "
|4.||Drug Therapy (Chemotherapy)
04/01/2015 - "Development of photodermatoses is not an absolute contraindication to continuing chemotherapy, provided that the cutaneous condition resolves with dermatosis-directed treatment and the patient avoids sun exposure."
04/01/2015 - "Chemotherapy can be associated with adverse mucocutaneous events, including dermatoses on sun-exposed areas of the skin. "
06/01/2011 - "Topiucal drug therapy is an intuitively sound approach to the management of skin diseases. "
09/01/2010 - "Traditional/Ayurvedic pharmacotherapy for skin diseases."
03/01/2010 - "The most efficient treatment of this dermatosis appears to be specific chemotherapy for the blood dyscrasia. "
01/01/2010 - "Paraneoplastic dermatoses were obviously improved after treatment, which was first reported. "
07/01/2008 - "Period of remission after treatment with UVA-1 in sclerodermic skin diseases."
08/15/2002 - "In the patient with skin disease, the lesions began to resolve shortly after treatment began. "
06/01/1996 - "This system may help provide information about microvascular pathophysiology in skin diseases before and after treatment."
01/01/1996 - "In both groups, the TSP levels correlated positively with skin disease severity score from the onset to 2 months after treatment. "